Table 5

Mean difference in change in Health Assessment Questionnaire (HAQ) over 10 years by time to, and time receiving, treatment—adjusted by baseline HAQ and marginal structural weight

Difference in change in HAQ between baseline and year 10, compared with never treated
Adjusted by baseline HAQAdjusted by marginal structural weight
nMean(95% CI)Mean(95% CI)
Treated over follow-up3450.30(0.18 to 0.42)−0.01(−0.20 to 0.19)
Time to first treatment
 <6 Months1220.13−0.04 to 0.3)−0.24(−0.58 to 0.09)
 6–12 Months760.35(0.15 to 0.54)0.12(−0.13 to 0.37)
 >12 Months1470.39(0.24 to 0.54)0.18(−0.06 to 0.41)
Effect of first treatment duration
 ≤6 Months910.41(0.23 to 0.59)0.28(0.04 to 0.52)
 >6–≤36 Months123−0.10(−0.31 to 0.1)−0.25(−0.56 to 0.06)
 >36 Months131−0.10(−0.28 to 0.09)−0.37(−0.77 to 0.04)
Effect of treatment duration over 10 years
 ≤48 Months880.08(−0.1 to 0.26)−0.21(−0.62 to 0.21)
 >48–≤96 Months570.35(0.1 to 0.6)0.53(−0.01 to 1.06)
 >96 Months200−0.07(−0.29 to 0.15)−0.37(−0.77 to 0.04)
Effect per number of months of first treatment
 No of months treated in first 6 months since symptom onset−0.09(−0.15 to −0.03)−0.09(−0.17 to −0.01)
 No of months treated after first 6 months since symptom onset−0.002(−0.004 to 0.0001)−0.004(−0.01 to −0.0004)
Effect per number of months of treatment over 10 years
 No of months treated in first 6 months since symptom onset−0.10(−0.16 to −0.04)−0.10(−0.19 to −0.02)
 No of months treated after first 6 months since symptom onset0.003(0.001 to 0.005)0.001(−0.002 to 0.005)